Privacy Policy Quotes



Glaxo issued Avandia a drug for diabetes, but the company began receiving reports of heart attacks and other cardio-vascular problems occurring with the drug. A team gathered the data and summarized it for the Senior Management. Drug companies are required by law to inform the FDA of any adverse data that they may know about relative to any of their drugs. Glaxo did not. Further, the Senior management ordered the data “suppressed” and it was so for a decade. Finally the e-mail was leaked to a Congressional Committee when there were other data coming in about the problems with Avandia. The FDA began a new review of the safety of Avandia, but the company had the profits for a decade. Some people had dead friends and relatives. It was generally thought that this sort of thing would never happen in an industry where all the companies are very substantial and a loss of income of any drug would not bankrupt the company, but more and more incidents began coming to light in the early 21st century.